Timothy M. Shannon, Director at CytomX Therapeutics, Inc. (CTMX), sold 76,918 shares at $11.33 ($889K) on 2016-11-28, disclosed to the SEC on 2016-11-28.
Open-market sale of $889k CTMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.84 | 10,890 | $129K | 14.5% |
| 2 | $11.84 | 10,890 | $129K | 14.5% |
| 3 | $11.79 | 6,729 | $79K | 8.9% |
| 4 | $11.79 | 6,729 | $79K | 8.9% |
| 5 | $11.33 | 20,840 | $236K | 26.6% |
| 6 | $11.33 | 20,840 |
| $236K |
| 26.6% |
| Total | $11.55 avg | 76,918 | $889K | 100% |
| Filing → |
| ARVN | SELL | 2021-09-27 | $4.3M | — | Filing → |
| ARVN | SELL | 2021-09-27 | $32.9M | — | Filing → |
| RLYB | BUY | 2021-08-04 | $1000K | — | Filing → |